Affordable Access

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.

Authors
Type
Published Article
Journal
Gut
Publication Date
Volume
55
Issue
8
Pages
1131–1137
Identifiers
PMID: 16507585
Source
Medline

Abstract

Statistics

Seen <100 times